美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Global Partners Lp

52.80

-0.3075-0.58%

成交量：1.27万

成交额：67.38万

市值：17.95亿

市盈率：20.31

高：53.24

开：52.51

低：52.51

收：53.11

52周最高：60.00

52周最低：40.66

股本：3,399.56万

流通股本：2,767.42万

量比：0.22

换手率：0.05%

股息：2.97

股息率：5.62%

每股收益(TTM):2.60

每股收益(LYR):2.45

净资产收益率：16.33%

总资产收益率：4.09%

市净率：2.94

市盈率(LYR):21.59

数据加载中...

总览公司新闻公告

一款具有同类最佳减重与食欲抑制作用的口服小分子GLP-1受体激动剂| 药时代BD项目

【上证医药】银诺医药登陆港交所，关注国产GLP-1商业化落地进程——医药生物行业周报（20250811-0815）

上海证券研究

由于Viking Therapeutics(VKTX.US)旗下实验性口服减肥药的中期试验数据不及预期截至发稿该股周二美

Viking(VKTX.US)盘前暴跌！口服减肥药VK2735中期试验结果不及预期

GLP-1开打！诺和诺德、礼来大降价，石药、四环医药报产，入局玩家谁能突围？

医药经济报

277%暗盘疯涨！GLP-1国产第一股引爆港交所

CPHI制药在线

GLP-1 药物，杀进脂肪肝市场

华尔街见闻

诺和诺德盘前涨超2%FDA批准公司的Wegovy作为首个用于治疗肝脏疾病的GLP-1药物。

【国投证券 | 医药】新药周观点：司美格鲁肽获批MASH，国产GLP-1出海值得关注

国投证券医药研究

港股异动 | 派格生物医药-B(02565)再涨超15%创上市新高 GLP-1板块热度升温公司内在价值有望加速释放

歌礼制药-B(01672)：ASC47与GLP-1R/GIPR双受体激动剂多肽ASC31联用在肥胖动物模型中显示出优于ASC47与替尔泊肽联用的减重效果

歌礼制药(1672.HK)宣布，其双重GLP-1R/GIPR肽激动剂ASC47与ASC31联用，在肥胖动物模型中显示出相

18A新股疯狂：只靠GLP-1，炒到了240亿

医药行业周报：全球GLP-1市场稳定扩容关注国内企业的授权机会

诺和诺德(NVO.US)GLP-1赛道再下一城：Wegovy获FDA批准用于治疗肝病，近1500万美国患者适用

司美格鲁肽获FDA批准治疗MASH

资本也爱GLP-1，认购比蜜雪冰城还火爆！银诺医药敲钟港股，盘中暴涨近300%

国产 GLP-1 先锋杀入港交所

Insight数据库

银诺医药-B(02591)暗盘暴涨270%引市场聚焦GLP-1赛道，派格生物医药-B(02565)价值洼地增长可期

创新药动态更新：GLP-1小分子：口服GLP-1小分子受体激动剂达到三期临床终点，国产潜在BIC管线在美国临床展示减重潜力

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/GLP/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GLP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLP\",,,,,undefined,":{"symbol":"GLP","market":"US","secType":"STK","nameCN":"Global Partners Lp","latestPrice":52.8025,"timestamp":1756839383185,"preClose":53.11,"halted":0,"volume":12743,"delay":0,"floatShares":27674174,"shares":33995563,"eps":2.600398,"marketStatus":"交易中","change":-0.3075,"latestTime":"09-02 14:58:38 EDT","open":52.5107,"high":53.2436,"low":52.5107,"amount":673793.324795,"amplitude":0.0138,"askPrice":53.52,"askSize":100,"bidPrice":52.5,"bidSize":27,"shortable":3,"etf":0,"ttmEps":2.600398,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1756843200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1127966400000,"exchange":"NYSE","adjPreClose":53.11,"dividendRate":0.056247,"preHourTrading":{"tag":"盘前","latestPrice":52.9,"preClose":53.11,"latestTime":"08:50 EDT","volume":15,"amount":793.5,"timestamp":1756817422314},"postHourTrading":{"tag":"盘后","latestPrice":53.11,"preClose":53.11,"latestTime":"16:10 EDT","volume":458,"amount":24324.38,"timestamp":1756498204619},"volumeRatio":0.22037,"impliedVol":0.3118,"impliedVolPercentile":0.344},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLP\",,,,,undefined,":{"symbol":"GLP","floatShares":27674174,"roa":"4.09%","roe":"16.33%","lyrEps":2.44604,"volumeRatio":0.22037,"shares":33995563,"dividePrice":2.97,"high":53.2436,"amplitude":0.0138,"preClose":53.11,"low":52.5107,"week52Low":40.66,"pbRate":"2.94","psRate":"0.10","week52High":60,"institutionHeld":0.4647,"latestPrice":52.8025,"committee":-0.574803,"eps":2.600398,"divideRate":0.056247,"volume":12743,"delay":0,"ttmEps":2.600398,"open":52.5107,"prevYearClose":46.55,"prevWeekClose":53.11,"prevMonthClose":53.11,"prevQuarterClose":52.73,"fiveDayClose":51.12,"twentyDayClose":52.16,"sixtyDayClose":53.15},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLP\",params:#limit:5,,,undefined,":[{"date":"2025-08-08","symbol":"GLP","amount":0.75,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-08","defaultRemindTime":1754659800000,"name":"Global Partners Lp","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-14","payableDate":"2025-08-08","currency":"USD","dateTimestamp":1754625600000,"payDate":"2025-08-14"},{"market":"US","date":"2025-08-07","symbol":"GLP","fiscalQuarterEnding":"2025/06","expectedEps":0.6,"name":null,"time":"盘前","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":0.55},{"date":"2025-05-09","symbol":"GLP","amount":0.745,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-09","defaultRemindTime":1746797400000,"name":"Global Partners Lp","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-15","payableDate":"2025-05-09","currency":"USD","dateTimestamp":1746763200000,"payDate":"2025-05-15"},{"market":"US","date":"2025-05-08","symbol":"GLP","fiscalQuarterEnding":"2025/03","expectedEps":-0.03,"name":null,"time":"盘前","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":0.36},{"market":"US","date":"2025-02-28","symbol":"GLP","fiscalQuarterEnding":"2024/12","expectedEps":0.24,"name":null,"time":"盘前","type":"earning","dateTimestamp":1740718800000,"reportTimeType":"pre","actualEps":0.52}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLP\",market:\"US\",,,undefined,":[{"executeDate":"2015-11-02","recordDate":"2015-11-04","paymentDate":"2015-11-13","value":0.6975,"currency":"USD"},{"executeDate":"2016-02-08","recordDate":"2016-02-10","paymentDate":"2016-02-16","value":0.4625,"currency":"USD"},{"executeDate":"2016-05-04","recordDate":"2016-05-06","paymentDate":"2016-05-16","value":0.4625,"currency":"USD"},{"executeDate":"2016-08-04","recordDate":"2016-08-08","paymentDate":"2016-08-12","value":0.4625,"currency":"USD"},{"executeDate":"2016-11-04","recordDate":"2016-11-08","paymentDate":"2016-11-14","value":0.4625,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":2,"updateTime":1741233600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GLP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GLP","date":"2025-08-29","current":18.669318,"percent":0.886838,"low":2.771386,"twenty":4.440923,"median":10.032501,"eighty":15.848057,"high":29.34912,"avg":10.924102,"sd":6.358204,"marketCap":1796753795},"quantilePoints":[{"date":"2020-09-04","current":4.542915,"twenty":6.2824,"median":8.213544,"eighty":11.285346,"marketCap":420437682},{"date":"2020-09-11","current":4.749076,"twenty":6.27606,"median":8.174338,"eighty":11.274368,"marketCap":439517512},{"date":"2020-09-18","current":4.815342,"twenty":6.275736,"median":8.086126,"eighty":11.269162,"marketCap":445650315},{"date":"2020-09-25","current":4.73435,"twenty":6.258044,"median":8.00583,"eighty":11.265698,"marketCap":438154667},{"date":"2020-10-02","current":4.933149,"twenty":6.250305,"median":7.971673,"eighty":11.259925,"marketCap":456553075},{"date":"2020-10-09","current":5.360198,"twenty":6.244429,"median":7.94745,"eighty":11.2525,"marketCap":496075580},{"date":"2020-10-16","current":5.26448,"twenty":6.239772,"median":7.932539,"eighty":11.247278,"marketCap":487217087},{"date":"2020-10-23","current":5.271843,"twenty":6.23717,"median":7.912422,"eighty":11.243223,"marketCap":487898510},{"date":"2020-10-30","current":5.338109,"twenty":6.227089,"median":7.896854,"eighty":11.239367,"marketCap":494031312},{"date":"2020-11-06","current":5.459545,"twenty":6.22179,"median":7.88907,"eighty":11.21862,"marketCap":522855188},{"date":"2020-11-13","current":5.670214,"twenty":6.203808,"median":7.87934,"eighty":11.19873,"marketCap":543030764},{"date":"2020-11-20","current":5.877313,"twenty":6.196135,"median":7.85015,"eighty":11.194013,"marketCap":562864382},{"date":"2020-11-27","current":6.170107,"twenty":6.185826,"median":7.85015,"eighty":11.189536,"marketCap":590905013},{"date":"2020-12-04","current":6.109406,"twenty":6.168749,"median":7.838474,"eighty":11.169685,"marketCap":585091712},{"date":"2020-12-11","current":6.416483,"twenty":6.167844,"median":7.834582,"eighty":11.145422,"marketCap":614500179},{"date":"2020-12-18","current":6.230809,"twenty":6.167844,"median":7.828744,"eighty":11.130907,"marketCap":596718315},{"date":"2020-12-24","current":6.048705,"twenty":6.167844,"median":7.82096,"eighty":11.115597,"marketCap":579278410},{"date":"2020-12-31","current":5.934444,"twenty":6.167844,"median":7.817068,"eighty":11.101741,"marketCap":568335725},{"date":"2021-01-08","current":6.062987,"twenty":6.149862,"median":7.795662,"eighty":11.084422,"marketCap":580646246},{"date":"2021-01-15","current":6.216526,"twenty":6.149862,"median":7.785585,"eighty":11.084422,"marketCap":595350479},{"date":"2021-01-22","current":6.705707,"twenty":6.149862,"median":7.780094,"eighty":11.074992,"marketCap":642198851},{"date":"2021-01-29","current":7.180605,"twenty":6.149862,"median":7.776202,"eighty":11.068208,"marketCap":687679388},{"date":"2021-02-05","current":7.284155,"twenty":6.149862,"median":7.768418,"eighty":11.06411,"marketCap":697596196},{"date":"2021-02-12","current":6.934229,"twenty":6.163202,"median":7.760634,"eighty":11.053134,"marketCap":664084222},{"date":"2021-02-19","current":7.112763,"twenty":6.167321,"median":7.75285,"eighty":11.04396,"marketCap":681182168},{"date":"2021-02-26","current":7.202029,"twenty":6.167844,"median":7.741174,"eighty":11.038761,"marketCap":689731141},{"date":"2021-03-05","current":6.896217,"twenty":6.167844,"median":7.718575,"eighty":11.032407,"marketCap":695214499},{"date":"2021-03-12","current":7.842623,"twenty":6.167844,"median":7.698362,"eighty":11.017031,"marketCap":790622686},{"date":"2021-03-19","current":7.720506,"twenty":6.167844,"median":7.718575,"eighty":11.007626,"marketCap":778311953},{"date":"2021-03-26","current":7.411822,"twenty":6.167844,"median":7.69367,"eighty":11.00501,"marketCap":747193153},{"date":"2021-04-01","current":7.320234,"twenty":6.167844,"median":7.686686,"eighty":10.988222,"marketCap":737960103},{"date":"2021-04-09","current":7.3779,"twenty":6.167844,"median":7.67501,"eighty":10.954813,"marketCap":743773505},{"date":"2021-04-16","current":7.510194,"twenty":6.168749,"median":7.659442,"eighty":10.940212,"marketCap":757110133},{"date":"2021-04-23","current":7.364332,"twenty":6.170107,"median":7.594997,"eighty":10.930856,"marketCap":742405645},{"date":"2021-04-30","current":8.185229,"twenty":6.171613,"median":7.641929,"eighty":10.912383,"marketCap":825161134},{"date":"2021-05-07","current":9.181725,"twenty":6.178654,"median":7.67501,"eighty":10.905455,"marketCap":849502414},{"date":"2021-05-14","current":8.749253,"twenty":6.185826,"median":7.686686,"eighty":10.905455,"marketCap":809489619},{"date":"2021-05-21","current":9.203903,"twenty":6.185826,"median":7.690578,"eighty":10.897433,"marketCap":851554353},{"date":"2021-05-28","current":9.407203,"twenty":6.185826,"median":7.712361,"eighty":10.877257,"marketCap":870363786},{"date":"2021-06-04","current":9.706607,"twenty":6.189262,"median":7.720506,"eighty":10.864653,"marketCap":898064952},{"date":"2021-06-11","current":10.061456,"twenty":6.203126,"median":7.741174,"eighty":10.858681,"marketCap":930895963},{"date":"2021-06-18","current":9.603109,"twenty":6.203644,"median":7.748958,"eighty":10.836624,"marketCap":888489240},{"date":"2021-06-25","current":9.680732,"twenty":6.203808,"median":7.760634,"eighty":10.817799,"marketCap":895671024},{"date":"2021-07-02","current":9.658554,"twenty":6.203808,"median":7.768418,"eighty":10.809851,"marketCap":893619086},{"date":"2021-07-09","current":9.31849,"twenty":6.203808,"median":7.778148,"eighty":10.796921,"marketCap":862156033},{"date":"2021-07-16","current":8.963641,"twenty":6.213362,"median":7.780094,"eighty":10.785892,"marketCap":829325022},{"date":"2021-07-23","current":9.495915,"twenty":6.213362,"median":7.785616,"eighty":10.763835,"marketCap":878571539},{"date":"2021-07-30","current":9.909906,"twenty":6.216526,"median":7.795662,"eighty":10.752807,"marketCap":916874385},{"date":"2021-08-06","current":29.34912,"twenty":6.22179,"median":7.817068,"eighty":10.752807,"marketCap":823536295},{"date":"2021-08-13","current":26.023372,"twenty":6.22179,"median":7.822906,"eighty":10.813084,"marketCap":730215805},{"date":"2021-08-20","current":24.554702,"twenty":6.22179,"median":7.83069,"eighty":10.865043,"marketCap":689004931},{"date":"2021-08-27","current":24.530426,"twenty":6.22179,"median":7.834582,"eighty":10.905455,"marketCap":688323760},{"date":"2021-09-03","current":25.100901,"twenty":6.22179,"median":7.842494,"eighty":10.964493,"marketCap":704331289},{"date":"2021-09-10","current":24.275533,"twenty":6.228856,"median":7.848204,"eighty":11.013201,"marketCap":681171460},{"date":"2021-09-17","current":25.198003,"twenty":6.230622,"median":7.85015,"eighty":11.053134,"marketCap":707055975},{"date":"2021-09-24","current":24.894559,"twenty":6.230772,"median":7.876969,"eighty":11.084422,"marketCap":698541332},{"date":"2021-10-01","current":26.047647,"twenty":6.233421,"median":7.883329,"eighty":11.141011,"marketCap":730896976},{"date":"2021-10-08","current":26.897291,"twenty":6.234318,"median":7.892962,"eighty":11.19642,"marketCap":754737977},{"date":"2021-10-15","current":26.836602,"twenty":6.236185,"median":7.896854,"eighty":11.246674,"marketCap":753035049},{"date":"2021-10-22","current":28.632991,"twenty":6.237348,"median":7.914368,"eighty":11.269162,"marketCap":803441737},{"date":"2021-10-29","current":28.329547,"twenty":6.237865,"median":7.935774,"eighty":11.303569,"marketCap":794927093},{"date":"2021-11-05","current":18.151279,"twenty":6.239408,"median":7.94745,"eighty":11.328048,"marketCap":776838422},{"date":"2021-11-12","current":18.191189,"twenty":6.239772,"median":7.988112,"eighty":11.346522,"marketCap":778546510},{"date":"2021-11-19","current":18.773882,"twenty":6.239772,"median":8.014118,"eighty":11.360961,"marketCap":803484595},{"date":"2021-11-26","current":18.694061,"twenty":6.239772,"median":8.035981,"eighty":11.378852,"marketCap":800068419},{"date":"2021-12-03","current":18.103386,"twenty":6.239772,"median":8.105729,"eighty":11.403489,"marketCap":774788716},{"date":"2021-12-10","current":18.430652,"twenty":6.240495,"median":8.179783,"eighty":11.427136,"marketCap":788795038},{"date":"2021-12-17","current":18.550383,"twenty":6.243048,"median":8.213544,"eighty":11.470285,"marketCap":793919302},{"date":"2021-12-23","current":17.991637,"twenty":6.244429,"median":8.252749,"eighty":11.474686,"marketCap":770006070},{"date":"2021-12-31","current":18.749936,"twenty":6.244429,"median":8.284603,"eighty":11.575574,"marketCap":802459742},{"date":"2022-01-07","current":20.051017,"twenty":6.24581,"median":8.291955,"eighty":11.616705,"marketCap":858143411},{"date":"2022-01-14","current":21.152545,"twenty":6.248234,"median":8.320498,"eighty":11.690231,"marketCap":905286640},{"date":"2022-01-21","current":20.146802,"twenty":6.249277,"median":8.363015,"eighty":11.729858,"marketCap":862242822},{"date":"2022-01-28","current":21.392008,"twenty":6.251718,"median":8.365465,"eighty":11.776801,"marketCap":915535168},{"date":"2022-02-04","current":21.85497,"twenty":6.254157,"median":8.433466,"eighty":11.837284,"marketCap":935348988},{"date":"2022-02-11","current":21.559632,"twenty":6.257754,"median":8.47328,"eighty":11.938846,"marketCap":922709137},{"date":"2022-02-18","current":20.945011,"twenty":6.257851,"median":8.48054,"eighty":12.432666,"marketCap":896404582},{"date":"2022-02-25","current":20.529942,"twenty":6.258237,"median":8.487891,"eighty":12.775373,"marketCap":878640467},{"date":"2022-03-04","current":15.348683,"twenty":6.268592,"median":8.571294,"eighty":13.121553,"marketCap":878174885},{"date":"2022-03-11","current":15.504022,"twenty":6.275496,"median":8.601399,"eighty":13.154839,"marketCap":887062603},{"date":"2022-03-18","current":15.940166,"twenty":6.275736,"median":8.649704,"eighty":13.201441,"marketCap":912016580},{"date":"2022-03-25","current":16.890123,"twenty":6.275736,"median":8.669307,"eighty":13.248042,"marketCap":966368393},{"date":"2022-04-01","current":16.214996,"twenty":6.275736,"median":8.68891,"eighty":13.261356,"marketCap":927741004},{"date":"2022-04-08","current":16.752708,"twenty":6.275736,"median":8.726599,"eighty":13.281328,"marketCap":958506181},{"date":"2022-04-14","current":16.573471,"twenty":6.275736,"median":8.736337,"eighty":13.3013,"marketCap":948251122},{"date":"2022-04-22","current":16.011861,"twenty":6.276168,"median":8.777122,"eighty":13.329261,"marketCap":916118604},{"date":"2022-04-29","current":15.743005,"twenty":6.281175,"median":8.797306,"eighty":13.342575,"marketCap":900736015},{"date":"2022-05-06","current":9.804164,"twenty":6.2824,"median":8.848712,"eighty":13.349233,"marketCap":897659497},{"date":"2022-05-13","current":9.69216,"twenty":6.2824,"median":8.9103,"eighty":13.347901,"marketCap":887404438},{"date":"2022-05-20","current":10.270852,"twenty":6.291454,"median":8.930374,"eighty":13.347901,"marketCap":940388910},{"date":"2022-05-27","current":11.163158,"twenty":6.293718,"median":8.972794,"eighty":13.342575,"marketCap":1022087547},{"date":"2022-06-03","current":10.868211,"twenty":6.294536,"median":8.995202,"eighty":13.341244,"marketCap":995082558},{"date":"2022-06-10","current":10.244717,"twenty":6.297672,"median":9.026396,"eighty":13.341244,"marketCap":937996063},{"date":"2022-06-17","current":7.754474,"twenty":6.299555,"median":9.016925,"eighty":13.33725,"marketCap":709991918},{"date":"2022-06-24","current":8.613179,"twenty":6.299659,"median":8.99034,"eighty":13.331924,"marketCap":788614037},{"date":"2022-07-01","current":8.814788,"twenty":6.299659,"median":8.977241,"eighty":13.322603,"marketCap":807073143},{"date":"2022-07-08","current":8.900658,"twenty":6.299659,"median":8.963641,"eighty":13.313284,"marketCap":814935355},{"date":"2022-07-15","current":8.867057,"twenty":6.299659,"median":8.92485,"eighty":13.306626,"marketCap":811858837},{"date":"2022-07-22","current":9.561487,"twenty":6.300172,"median":8.963641,"eighty":13.3013,"marketCap":875440203},{"date":"2022-07-29","current":10.371656,"twenty":6.303369,"median":8.980096,"eighty":13.299969,"marketCap":949618463},{"date":"2022-08-05","current":3.850073,"twenty":6.303369,"median":8.997729,"eighty":13.29198,"marketCap":927520968},{"date":"2022-08-12","current":4.016293,"twenty":6.299659,"median":8.972794,"eighty":13.281328,"marketCap":967565231},{"date":"2022-08-19","current":3.999245,"twenty":6.293991,"median":8.937993,"eighty":13.278687,"marketCap":963458127},{"date":"2022-08-26","current":3.899797,"twenty":6.2824,"median":8.919306,"eighty":13.268103,"marketCap":939500021},{"date":"2022-09-02","current":4.077383,"twenty":6.275736,"median":8.9103,"eighty":13.268014,"marketCap":982282354},{"date":"2022-09-09","current":4.169728,"twenty":6.275496,"median":8.900658,"eighty":13.268014,"marketCap":1004529167},{"date":"2022-09-16","current":4.014873,"twenty":6.257754,"median":8.857885,"eighty":13.261356,"marketCap":967222973},{"date":"2022-09-23","current":3.607134,"twenty":6.247881,"median":8.814788,"eighty":13.254699,"marketCap":868994737},{"date":"2022-09-30","current":3.51621,"twenty":6.240977,"median":8.791187,"eighty":13.254699,"marketCap":847090183},{"date":"2022-10-07","current":3.916845,"twenty":6.239772,"median":8.777122,"eighty":13.248042,"marketCap":943607125},{"date":"2022-10-14","current":3.740679,"twenty":6.236636,"median":8.755886,"eighty":13.248042,"marketCap":901167051},{"date":"2022-10-21","current":4.087328,"twenty":6.230622,"median":8.734756,"eighty":13.241384,"marketCap":984678164},{"date":"2022-10-28","current":4.250707,"twenty":6.22179,"median":8.716798,"eighty":13.234727,"marketCap":1024037910},{"date":"2022-11-04","current":3.449288,"twenty":6.213362,"median":8.68891,"eighty":13.208098,"marketCap":1095762902},{"date":"2022-11-11","current":3.301892,"twenty":6.203808,"median":8.669307,"eighty":13.201441,"marketCap":1048938349},{"date":"2022-11-18","current":3.311575,"twenty":6.185826,"median":8.649704,"eighty":13.194783,"marketCap":1052014414},{"date":"2022-11-25","current":3.399797,"twenty":6.17312,"median":8.639313,"eighty":13.17348,"marketCap":1080040789},{"date":"2022-12-02","current":3.385811,"twenty":6.167844,"median":8.62969,"eighty":13.162828,"marketCap":1075597583},{"date":"2022-12-09","current":3.518145,"twenty":6.167844,"median":8.601399,"eighty":13.156171,"marketCap":1117637146},{"date":"2022-12-16","current":3.574091,"twenty":6.149862,"median":8.577106,"eighty":13.154839,"marketCap":1135409969},{"date":"2022-12-23","current":3.865656,"twenty":6.146266,"median":8.549709,"eighty":13.144188,"marketCap":1228033720},{"date":"2022-12-30","current":3.740853,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1188386653},{"date":"2023-01-06","current":3.441757,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1093370406},{"date":"2023-01-13","current":3.612823,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1147714231},{"date":"2023-01-20","current":3.620354,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1150106726},{"date":"2023-01-27","current":3.857048,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1225299440},{"date":"2023-02-03","current":4.130323,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1312112845},{"date":"2023-02-10","current":3.93774,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1250933319},{"date":"2023-02-17","current":3.875339,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1231109786},{"date":"2023-02-24","current":3.718259,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1181209167},{"date":"2023-03-03","current":3.363192,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1194165378},{"date":"2023-03-10","current":3.211151,"twenty":6.113691,"median":8.482899,"eighty":13.133536,"marketCap":1140180220},{"date":"2023-03-17","current":2.830086,"twenty":6.097582,"median":8.463126,"eighty":13.133536,"marketCap":1004875645},{"date":"2023-03-24","current":2.875313,"twenty":6.070129,"median":8.365465,"eighty":13.133536,"marketCap":1020934521},{"date":"2023-03-31","current":2.985014,"twenty":6.034422,"median":8.291955,"eighty":13.130873,"marketCap":1059885838},{"date":"2023-04-06","current":2.892634,"twenty":6.016569,"median":8.274802,"eighty":13.130873,"marketCap":1027084729},{"date":"2023-04-14","current":2.896483,"twenty":5.960153,"median":8.185229,"eighty":13.133536,"marketCap":1028451442},{"date":"2023-04-20","current":2.925352,"twenty":5.879004,"median":8.105729,"eighty":13.133536,"marketCap":1038701788},{"date":"2023-04-28","current":2.932088,"twenty":5.726233,"median":7.998046,"eighty":13.136199,"marketCap":1041093536},{"date":"2023-05-05","current":2.771386,"twenty":5.536171,"median":7.943558,"eighty":13.136199,"marketCap":984033273},{"date":"2023-05-12","current":2.975648,"twenty":5.442294,"median":7.932539,"eighty":13.136199,"marketCap":1050433502},{"date":"2023-05-19","current":3.089052,"twenty":5.341054,"median":7.932539,"eighty":13.136199,"marketCap":1090466310},{"date":"2023-05-26","current":2.874844,"twenty":5.253436,"median":7.932539,"eighty":13.136199,"marketCap":1014848784},{"date":"2023-06-02","current":2.846736,"twenty":5.130475,"median":7.932539,"eighty":13.136199,"marketCap":1004926122},{"date":"2023-06-09","current":3.07839,"twenty":5.004569,"median":7.932539,"eighty":13.136199,"marketCap":1086702542},{"date":"2023-06-16","current":3.058036,"twenty":4.918423,"median":7.932539,"eighty":13.136199,"marketCap":1079517166},{"date":"2023-06-23","current":2.916523,"twenty":4.864674,"median":7.935774,"eighty":13.138862,"marketCap":1029561696},{"date":"2023-06-30","current":2.952386,"twenty":4.815342,"median":7.93772,"eighty":13.141525,"marketCap":1042221644},{"date":"2023-07-07","current":2.944631,"twenty":4.771165,"median":7.93772,"eighty":13.141525,"marketCap":1039484358},{"date":"2023-07-14","current":3.066759,"twenty":4.749076,"median":7.93772,"eighty":13.141525,"marketCap":1082596613},{"date":"2023-07-21","current":3.116192,"twenty":4.697536,"median":7.93772,"eighty":13.141525,"marketCap":1100046811},{"date":"2023-07-28","current":3.215057,"twenty":4.671766,"median":7.93772,"eighty":13.141525,"marketCap":1134947207},{"date":"2023-08-04","current":3.279998,"twenty":4.616544,"median":7.93772,"eighty":13.141525,"marketCap":1157871978},{"date":"2023-08-11","current":4.645552,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075069076},{"date":"2023-08-18","current":4.647031,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075411237},{"date":"2023-08-25","current":4.663295,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1079175005},{"date":"2023-09-01","current":4.624853,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1070278826},{"date":"2023-09-08","current":4.647031,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075411237},{"date":"2023-09-15","current":4.775663,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1105179222},{"date":"2023-09-22","current":4.867332,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1126393189},{"date":"2023-09-29","current":5.173389,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1197220464},{"date":"2023-10-06","current":4.475521,"twenty":4.542915,"median":7.93772,"eighty":13.141525,"marketCap":1035720590},{"date":"2023-10-13","current":4.511006,"twenty":4.484012,"median":7.93772,"eighty":13.141525,"marketCap":1043932448},{"date":"2023-10-20","current":4.482914,"twenty":4.482914,"median":7.93772,"eighty":13.141525,"marketCap":1037431394},{"date":"2023-10-27","current":4.534662,"twenty":4.467537,"median":7.94745,"eighty":13.149513,"marketCap":1049407020},{"date":"2023-11-03","current":4.904296,"twenty":4.458666,"median":7.94745,"eighty":13.149513,"marketCap":1134947207},{"date":"2023-11-10","current":7.439549,"twenty":4.458666,"median":7.935774,"eighty":13.149513,"marketCap":1088071185},{"date":"2023-11-17","current":7.820894,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1143844827},{"date":"2023-11-24","current":7.993518,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1169092039},{"date":"2023-12-01","current":8.460278,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1237357955},{"date":"2023-12-08","current":8.743603,"twenty":4.459848,"median":7.902692,"eighty":13.146851,"marketCap":1278795691},{"date":"2023-12-15","current":8.690189,"twenty":4.459848,"median":7.902692,"eighty":13.146851,"marketCap":1270983658},{"date":"2023-12-22","current":9.616802,"twenty":4.459848,"median":7.934448,"eighty":13.146851,"marketCap":1406505433},{"date":"2023-12-29","current":9.686473,"twenty":4.4563,"median":7.940074,"eighty":13.154839,"marketCap":1416695040},{"date":"2024-01-05","current":9.75382,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1426544994},{"date":"2024-01-12","current":9.809556,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1434696679},{"date":"2024-01-19","current":10.16023,"twenty":4.448612,"median":7.939666,"eighty":13.154839,"marketCap":1485984368},{"date":"2024-01-26","current":10.740814,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1570897761},{"date":"2024-02-02","current":10.601474,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1550518547},{"date":"2024-02-09","current":10.963759,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1603504503},{"date":"2024-02-16","current":11.124,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1626940600},{"date":"2024-02-23","current":10.647921,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1557311618},{"date":"2024-03-01","current":11.10678,"twenty":4.4563,"median":7.940074,"eighty":13.154839,"marketCap":1583804596},{"date":"2024-03-08","current":11.32675,"twenty":4.4563,"median":7.94745,"eighty":13.154839,"marketCap":1615171958},{"date":"2024-03-15","current":10.799262,"twenty":4.4563,"median":7.990262,"eighty":13.154839,"marketCap":1539953125},{"date":"2024-03-22","current":11.659401,"twenty":4.4563,"median":8.049544,"eighty":13.154839,"marketCap":1662607257},{"date":"2024-03-28","current":10.571159,"twenty":4.4563,"median":8.239503,"eighty":13.154839,"marketCap":1507426062},{"date":"2024-04-05","current":10.811142,"twenty":4.452456,"median":8.461702,"eighty":13.154839,"marketCap":1541647243},{"date":"2024-04-12","current":11.186562,"twenty":4.452456,"median":8.566313,"eighty":13.154839,"marketCap":1595181367},{"date":"2024-04-19","current":10.81827,"twenty":4.452456,"median":8.624771,"eighty":13.154839,"marketCap":1542663714},{"date":"2024-04-26","current":11.245964,"twenty":4.4563,"median":8.639313,"eighty":13.154839,"marketCap":1603651956},{"date":"2024-05-03","current":11.324374,"twenty":4.4563,"median":8.690189,"eighty":13.154839,"marketCap":1614833134},{"date":"2024-05-10","current":14.682959,"twenty":4.4563,"median":8.734756,"eighty":13.168154,"marketCap":1565364893},{"date":"2024-05-17","current":13.78037,"twenty":4.4563,"median":8.734756,"eighty":13.224197,"marketCap":1469138999},{"date":"2024-05-24","current":14.166489,"twenty":4.4563,"median":8.734756,"eighty":13.241384,"marketCap":1510303519},{"date":"2024-05-31","current":15.403069,"twenty":4.4563,"median":8.734756,"eighty":13.248042,"marketCap":1642136538},{"date":"2024-06-07","current":15.399881,"twenty":4.4563,"median":8.734756,"eighty":13.254699,"marketCap":1641796762},{"date":"2024-06-14","current":15.042931,"twenty":4.4563,"median":8.734756,"eighty":13.254699,"marketCap":1603741870},{"date":"2024-06-21","current":14.389583,"twenty":4.452456,"median":8.72747,"eighty":13.257384,"marketCap":1534087827},{"date":"2024-06-28","current":14.542562,"twenty":4.452456,"median":8.72747,"eighty":13.270766,"marketCap":1550397066},{"date":"2024-07-05","current":14.395957,"twenty":4.452456,"median":8.72747,"eighty":13.285322,"marketCap":1534767378},{"date":"2024-07-12","current":13.586443,"twenty":4.452456,"median":8.72747,"eighty":13.285322,"marketCap":1448464320},{"date":"2024-07-19","current":12.767369,"twenty":4.452456,"median":8.72747,"eighty":13.228966,"marketCap":1361141934},{"date":"2024-07-26","current":12.910786,"twenty":4.452456,"median":8.72747,"eighty":13.052045,"marketCap":1376431846},{"date":"2024-08-02","current":13.302795,"twenty":4.452456,"median":8.72747,"eighty":12.924809,"marketCap":1418224272},{"date":"2024-08-09","current":12.449802,"twenty":4.452456,"median":8.72747,"eighty":12.75462,"marketCap":1335540014},{"date":"2024-08-16","current":13.196601,"twenty":4.452456,"median":8.72747,"eighty":12.789678,"marketCap":1415652134},{"date":"2024-08-23","current":13.473893,"twenty":4.452456,"median":8.72747,"eighty":13.02799,"marketCap":1445398406},{"date":"2024-08-30","current":14.204937,"twenty":4.452456,"median":8.72747,"eighty":13.191559,"marketCap":1523820396},{"date":"2024-09-06","current":13.316341,"twenty":4.452456,"median":8.72747,"eighty":13.222287,"marketCap":1428497115},{"date":"2024-09-13","current":13.558971,"twenty":4.452456,"median":8.72747,"eighty":13.305504,"marketCap":1454525103},{"date":"2024-09-20","current":14.226994,"twenty":4.452456,"median":8.72747,"eighty":13.395117,"marketCap":1526186577},{"date":"2024-09-27","current":14.085197,"twenty":4.452456,"median":8.72747,"eighty":13.544476,"marketCap":1510975415},{"date":"2024-10-04","current":14.976944,"twenty":4.452456,"median":8.72747,"eighty":13.679972,"marketCap":1606636722},{"date":"2024-10-11","current":14.803637,"twenty":4.452456,"median":8.72747,"eighty":13.85562,"marketCap":1588045302},{"date":"2024-10-18","current":14.529495,"twenty":4.452456,"median":8.72747,"eighty":14.019655,"marketCap":1558637056},{"date":"2024-10-25","current":14.772126,"twenty":4.452456,"median":8.72747,"eighty":14.168401,"marketCap":1584665044},{"date":"2024-11-01","current":14.778428,"twenty":4.452456,"median":8.72747,"eighty":14.27768,"marketCap":1585341095},{"date":"2024-11-08","current":13.141823,"twenty":4.452456,"median":8.73918,"eighty":14.377354,"marketCap":1640493731},{"date":"2024-11-15","current":13.379586,"twenty":4.452456,"median":8.78252,"eighty":14.377354,"marketCap":1670173717},{"date":"2024-11-22","current":14.322533,"twenty":4.452456,"median":8.81344,"eighty":14.377354,"marketCap":1787881840},{"date":"2024-11-29","current":15.251971,"twenty":4.452456,"median":8.883858,"eighty":14.399781,"marketCap":1903903601},{"date":"2024-12-06","current":15.273586,"twenty":4.452456,"median":8.934183,"eighty":14.482822,"marketCap":1906601781},{"date":"2024-12-13","current":14.4198,"twenty":4.452456,"median":9.012663,"eighty":14.537463,"marketCap":1800023652},{"date":"2024-12-20","current":12.93378,"twenty":4.452456,"median":9.090449,"eighty":14.537463,"marketCap":1614523744},{"date":"2024-12-27","current":12.995923,"twenty":4.452456,"median":9.19602,"eighty":14.537463,"marketCap":1622281013},{"date":"2025-01-03","current":12.766265,"twenty":4.452456,"median":9.268408,"eighty":14.537463,"marketCap":1593612846},{"date":"2025-01-10","current":12.631172,"twenty":4.448612,"median":9.31881,"eighty":14.538738,"marketCap":1576749218},{"date":"2025-01-17","current":14.282006,"twenty":4.448612,"median":9.382279,"eighty":14.538738,"marketCap":1782822752},{"date":"2025-01-24","current":13.892938,"twenty":4.448612,"median":9.455255,"eighty":14.538738,"marketCap":1734255503},{"date":"2025-01-31","current":14.63865,"twenty":4.448612,"median":9.481129,"eighty":14.558635,"marketCap":1827342730},{"date":"2025-02-07","current":15.684268,"twenty":4.448612,"median":9.514397,"eighty":14.63454,"marketCap":1957867210},{"date":"2025-02-14","current":15.462716,"twenty":4.448612,"median":9.568033,"eighty":14.675959,"marketCap":1930210860},{"date":"2025-02-21","current":15.732902,"twenty":4.448612,"median":9.580931,"eighty":14.694621,"marketCap":1963938116},{"date":"2025-02-28","current":20.937616,"twenty":4.448612,"median":9.626092,"eighty":14.774647,"marketCap":1933567942},{"date":"2025-03-07","current":19.49754,"twenty":4.444767,"median":9.675026,"eighty":14.838928,"marketCap":1800578330},{"date":"2025-03-14","current":19.960552,"twenty":4.444767,"median":9.675026,"eighty":14.901539,"marketCap":1843337016},{"date":"2025-03-21","current":19.362647,"twenty":4.444767,"median":9.689317,"eighty":15.017908,"marketCap":1788121076},{"date":"2025-03-28","current":19.698057,"twenty":4.444767,"median":9.708699,"eighty":15.110765,"marketCap":1819095871},{"date":"2025-04-04","current":17.87153,"twenty":4.444767,"median":9.75606,"eighty":15.125044,"marketCap":1650417909},{"date":"2025-04-11","current":17.576223,"twenty":4.448612,"median":9.799015,"eighty":15.243459,"marketCap":1623146621},{"date":"2025-04-17","current":18.509538,"twenty":4.448612,"median":9.802712,"eighty":15.283315,"marketCap":1709337357},{"date":"2025-04-25","current":18.910572,"twenty":4.444767,"median":9.80686,"eighty":15.360398,"marketCap":1746372438},{"date":"2025-05-02","current":18.710055,"twenty":4.444767,"median":9.80686,"eighty":15.401794,"marketCap":1727854897},{"date":"2025-05-09","current":14.05872,"twenty":4.444767,"median":9.80686,"eighty":15.43196,"marketCap":1621799891},{"date":"2025-05-16","current":14.406029,"twenty":4.444767,"median":9.80686,"eighty":15.43196,"marketCap":1661865116},{"date":"2025-05-23","current":14.373925,"twenty":4.444767,"median":9.80686,"eighty":15.43196,"marketCap":1658161608},{"date":"2025-05-30","current":15.450609,"twenty":4.444767,"median":9.80686,"eighty":15.444645,"marketCap":1782366767},{"date":"2025-06-06","current":15.621074,"twenty":4.444767,"median":9.80686,"eighty":15.514776,"marketCap":1802031456},{"date":"2025-06-13","current":16.520424,"twenty":4.444767,"median":9.80686,"eighty":15.572999,"marketCap":1905779645},{"date":"2025-06-20","current":16.170677,"twenty":4.440923,"median":9.804164,"eighty":15.627805,"marketCap":1865433127},{"date":"2025-06-27","current":15.57111,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1796267668},{"date":"2025-07-03","current":15.479999,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1785757230},{"date":"2025-07-11","current":15.432974,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1780332488},{"date":"2025-07-18","current":14.992116,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1729475533},{"date":"2025-07-25","current":15.333047,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1768804912},{"date":"2025-08-01","current":15.430035,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1779993442},{"date":"2025-08-08","current":17.700627,"twenty":4.440923,"median":9.82349,"eighty":15.67238,"marketCap":1703526003},{"date":"2025-08-15","current":17.97186,"twenty":4.440923,"median":9.917298,"eighty":15.726991,"marketCap":1729629785},{"date":"2025-08-22","current":17.975383,"twenty":4.440923,"median":9.97212,"eighty":15.765277,"marketCap":1729968795},{"date":"2025-08-29","current":18.669318,"twenty":4.440923,"median":10.032501,"eighty":15.848057,"marketCap":1796753795}],"updateTime":1756799785683},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLP\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2560127663","title":"一款具有同类最佳减重与食欲抑制作用的口服小分子GLP-1受体激动剂| 药时代BD项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2560127663","media":"药时代","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560127663?lang=zh_cn&edition=fundamental","pubTime":"2025-08-20 14:07","pubTimestamp":1755670046,"startTime":"0","endTime":"0","summary":"紧随其后，信达生物的创新口服小分子GLP-1R激动剂IBI3032于8月5日获得美国FDA的IND批准。随着全球肥胖和2型糖尿病等代谢性疾病发病率持续攀升，GLP-1受体激动剂正经历从注射向口服剂型的迭代升级。目前，药时代BD团队正在为一款具有同类最佳减重与食欲抑制作用的口服小分子GLP-1受体激动剂项目寻找潜在合作伙伴。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820141058a493506b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820141058a493506b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4590","BK4144","GLP"],"gpt_icon":0},{"id":"2560919098","title":"【上证医药】银诺医药登陆港交所，关注国产GLP-1商业化落地进程——医药生物行业周报（20250811-0815）","url":"https://stock-news.laohu8.com/highlight/detail?id=2560919098","media":"上海证券研究","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560919098?lang=zh_cn&edition=fundamental","pubTime":"2025-08-19 22:23","pubTimestamp":1755613406,"startTime":"0","endTime":"0","summary":"1主要观点近日，银诺医药正式在香港联合交易所主板挂牌上市。Wegovy拓展MASH新适应症；关注国产GLP-1上市推进及商业化落地进程。3报告来源报告名称：《银诺医药登陆港交所，关注国产GLP-1商业化落地进程——医药生物行业周报》分析师：张林晚Tel: 021-53686155E-mail: zhanglinwan@shzq.comSAC编号：S0870523010001研报发布日期： 2025年8月19日发布机构： 上海证券有限责任公司4","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250819222623a6ef51a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250819222623a6ef51a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4144","BK4590","GLP"],"gpt_icon":0},{"id":"2560419481","title":"由于Viking Therapeutics(VKTX.US)旗下实验性口服减肥药的中期试验数据不及预期截至发稿该股周二美","url":"https://stock-news.laohu8.com/highlight/detail?id=2560419481","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560419481?lang=zh_cn&edition=fundamental","pubTime":"2025-08-19 20:57","pubTimestamp":1755608270,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1868837300.USD","LU0106261372.USD","LU1291159041.SGD","LU0354030511.USD","BK4144","LU0820561909.HKD","LU0882574055.USD","LU2237438978.USD","NVO","LU1868836591.USD","LENZ","SG9999014914.USD","LU0122379950.USD","BK4581","LU1974910355.USD","LU2461242641.AUD","SG9999013999.USD","LU2602419157.SGD","LU2237443895.HKD","IE00BFTCPJ56.SGD","LU1988902786.USD","LU0316494557.USD","LU2265009873.SGD","LU2491050154.USD","LU0943347566.SGD","GLP","LU2552382215.SGD","LU0109394709.USD","LU2063271972.USD","LU2023250504.SGD","LU1983299246.USD","LU0823434740.USD","LU0385154629.USD","SG9999015978.USD","LU2237443622.USD","LU2491050071.SGD","SG9999001176.USD","161027","LU0882574139.USD","LU1093756325.SGD","LU1720051017.SGD","VKTX","LLY","LU0097036916.USD","LU0114720955.EUR","LU1917777945.USD","LU2456880835.USD","LU2462157665.USD","GIPR"],"gpt_icon":0},{"id":"2560914521","title":"Viking(VKTX.US)盘前暴跌！口服减肥药VK2735中期试验结果不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2560914521","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560914521?lang=zh_cn&edition=fundamental","pubTime":"2025-08-19 20:50","pubTimestamp":1755607814,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4599","LLY","LU1232071149.USD","LU1023059063.AUD","LU0114720955.EUR","LENZ","LU2471134952.CNY","LU2237443978.SGD","LU0122379950.USD","LU2602419157.SGD","LU2106854487.HKD","IE00B4R5TH58.HKD","LU0471298694.HKD","BK4139","GLP","LU2361044865.SGD","LU2471134879.HKD","LU2023250504.SGD","LU2468319806.SGD","LU2462157665.USD","LU0471298777.SGD","LU1868836914.USD","LU1035775433.USD","IE00BJJMRZ35.SGD","LU2491049909.HKD","SG9999015952.SGD","GIPR","SG9999001176.USD","LU0198837287.USD","IE00BKVL7J92.USD","LU2461242641.AUD","LU0820561909.HKD","LU1069344957.HKD","LU0289739699.SGD","SG9999014914.USD","VKTX","GB00BDT5M118.USD","IE00BJT1NW94.SGD","LU0823434583.USD","NVO","161027","IE00B1BXHZ80.USD","LU1093756325.SGD","LU1988902786.USD","LU2237443382.USD","LU0323591593.USD","LU0708995401.HKD","BK4144","LU1127390331.HKD"],"gpt_icon":0},{"id":"2560195490","title":"GLP-1开打！诺和诺德、礼来大降价，石药、四环医药报产，入局玩家谁能突围？","url":"https://stock-news.laohu8.com/highlight/detail?id=2560195490","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560195490?lang=zh_cn&edition=fundamental","pubTime":"2025-08-19 18:18","pubTimestamp":1755598718,"startTime":"0","endTime":"0","summary":"GoodRx的研究表明，1900万人在用于体重管理的GLP-1药物处方方面没有保险覆盖。此次合作正值GLP-1药物需求激增之际。8月16日，四环医药对外宣布，其控股子公司惠升生物开发的司美格鲁肽注射液，已经向国家药监局递交上市申请，用于改善成人2型糖尿病患者的血糖控制。不仅是国内，国际对GLP-1药物的追逐也势头正劲。日前，礼来公布2025年H1财报后遭遇股价大跌14%，究其深层原因是投资者对GLP-1市场持续增长的信心动摇。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250819192011a6ef01e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250819192011a6ef01e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LLY","IE00BK4W5M84.HKD","LU1974910355.USD","LU1988902786.USD","IE00BJT1NW94.SGD","LU2360106947.USD","LU0323591593.USD","LU2361044865.SGD","LU1548497426.USD","LU1868836757.USD","LU1868837136.USD","LU0316494557.USD","LU2471134523.USD","LU0708995401.HKD","LU0114720955.EUR","GLP","LU0466842654.USD","LU2750360641.GBP","LU2750360997.AUD","SG9999013999.USD","LU0417517546.SGD","SGXZ31699556.SGD","LU1061106388.HKD","IE0002141913.USD","LU2552382058.USD","SG9999014898.SGD","IE0004445239.USD","LU1623119135.USD","SGXZ51526630.SGD","LU2237443622.USD","LU2491050154.USD","LU0109394709.USD","LU2456880835.USD","LU0058720904.USD","NVO","LU0823434740.USD","SG9999015978.USD","SG9999018857.SGD","LU2211815571.USD","IE0009355771.USD","LU0456855351.SGD","LU1989771016.USD","LU2361045086.USD","BK4144","LU0820561909.HKD","LU0109391861.USD","SG9999014914.USD","LU2471134952.CNY","LU2746668461.USD","LU1366192091.USD"],"gpt_icon":1},{"id":"2560167813","title":"277%暗盘疯涨！GLP-1国产第一股引爆港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2560167813","media":"CPHI制药在线","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560167813?lang=zh_cn&edition=fundamental","pubTime":"2025-08-19 17:06","pubTimestamp":1755594366,"startTime":"0","endTime":"0","summary":"8月15日，银诺医药在香港联合交易所主板成功挂牌上市。在8月14日的暗盘交易中，银诺医药股价已暴涨超277%，创下年内新股纪录。机构预计，到2026年，用药患者比例将提升至2.9%，GLP-1渗透率将提升至35%，对应GLP-1肥胖适应症用药人数将从2024年的约90万人激增至265万人。目前，中国GLP-1市场已形成诺和诺德与礼来的\"双巨头\"格局。银诺医药的成功上市为本土GLP-1赛道增添了一个重量级参与者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250819175418a4919340&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250819175418a4919340&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4590","BK4144","GLP"],"gpt_icon":0},{"id":"2560165269","title":"GLP-1 药物，杀进脂肪肝市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2560165269","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560165269?lang=zh_cn&edition=fundamental","pubTime":"2025-08-19 15:42","pubTimestamp":1755589343,"startTime":"0","endTime":"0","summary":"司美格鲁肽获批Mash适应症，市场反应剧烈","market":"hk","thumbnail":"https://wpimg-wscn.awtmt.com/3c40a7d3-e069-45a9-914e-92944983460c.png","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/3c40a7d3-e069-45a9-914e-92944983460c.png"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3753616","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3753616","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["BK4144","BK4590","GLP"],"gpt_icon":0},{"id":"2560779149","title":"诺和诺德盘前涨超2%FDA批准公司的Wegovy作为首个用于治疗肝脏疾病的GLP-1药物。","url":"https://stock-news.laohu8.com/highlight/detail?id=2560779149","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560779149?lang=zh_cn&edition=fundamental","pubTime":"2025-08-18 16:19","pubTimestamp":1755505165,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4599","IE00BZ1G4Q59.USD","BK4007","GLP","BK4585","BK4144","BK4532","BK4590","LU1093756168.USD","IE00BKVL7J92.USD","LU1093756325.SGD","BK4588","NVO","LU0154236417.USD"],"gpt_icon":0},{"id":"2560909020","title":"【国投证券 | 医药】新药周观点：司美格鲁肽获批MASH，国产GLP-1出海值得关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2560909020","media":"国投证券医药研究","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560909020?lang=zh_cn&edition=fundamental","pubTime":"2025-08-18 14:53","pubTimestamp":1755500015,"startTime":"0","endTime":"0","summary":"既往获批上市的MASH治疗药物仅有THR-β抑制剂Resmetirom一款药物，本次GLP-1多肽司美格鲁肽的获批上市有望增加患者的治疗选择；同时新增的MASH适应症有望在糖尿病和减重适应症之外进一步增加GLP-1药物的销售规模。当前的超重或肥胖症患者中有超过三分之一同时患有MASH。MASH患者在疾病早期通常不会出现特异性症状，或症状轻微，常导致诊断延误。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818145610a6ec65c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818145610a6ec65c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLP","BK4144","BK4590"],"gpt_icon":0},{"id":"2560971246","title":"港股异动 | 派格生物医药-B(02565)再涨超15%创上市新高 GLP-1板块热度升温 公司内在价值有望加速释放","url":"https://stock-news.laohu8.com/highlight/detail?id=2560971246","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560971246?lang=zh_cn&edition=fundamental","pubTime":"2025-08-18 14:07","pubTimestamp":1755497239,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，派格生物医药-B再涨超15%，高见37港元再创上市新高。截至发稿，涨14.5%，报36.64港元，成交额2599.96万港元。消息面上，近日诺和诺德司美格鲁肽获批MASH新适应症，引发GLP-1板块热度。公开资料显示，派格生物医药是一家专注于自主研究及开发慢性病创新疗法的生物技术公司，旗下共有6款在研药物，其中有4条管线与GLP-1类药物相关，适应症几乎都是针对肥胖、超重、糖尿病等领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1330781.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["399441","BK4590","GLP","BK4144","02565","161726","BK1161"],"gpt_icon":0},{"id":"2560782039","title":"歌礼制药-B(01672)：ASC47与GLP-1R/GIPR双受体激动剂多肽ASC31联用在肥胖动物模型中显示出优于ASC47与替尔泊肽联用的减重效果","url":"https://stock-news.laohu8.com/highlight/detail?id=2560782039","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560782039?lang=zh_cn&edition=fundamental","pubTime":"2025-08-18 08:26","pubTimestamp":1755476763,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B 发布公告，公司董事宣布，同类首创的治疗肥胖症的减重不减肌候选药物ASC47与GLP-1受体/GIP受体双靶点激动剂多肽ASC31 联用显示出令人鼓舞的临床前疗效结果。ASC31是一款由歌礼自主研发的新型GLP-1R和GIPR双靶点激动剂多肽，在非人灵长类动物中显示出良好的药代动力学特征，同时显示出积极的体外活性并在 DIO小鼠中显示出积极的体内疗效。结果显示，ASC47联合ASC31治疗DIO小鼠平均减重 44.8%，比ASC47联合替尔泊肽多减重17.6%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1330651.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK4590","BK1191","BK4144","01477","BK1161","BK4160","GIPR","BK1574","GLP","01672"],"gpt_icon":0},{"id":"2560978477","title":"歌礼制药(1672.HK)宣布，其双重GLP-1R/GIPR肽激动剂ASC47与ASC31联用，在肥胖动物模型中显示出相","url":"https://stock-news.laohu8.com/highlight/detail?id=2560978477","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560978477?lang=zh_cn&edition=fundamental","pubTime":"2025-08-18 08:18","pubTimestamp":1755476312,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4144","01477","BK1161","BK1191","BK1515","BK4590","BK1574","GLP","GIPR","01672","BK4160"],"gpt_icon":0},{"id":"2560921816","title":"18A新股疯狂：只靠GLP-1，炒到了240亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2560921816","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560921816?lang=zh_cn&edition=fundamental","pubTime":"2025-08-17 12:37","pubTimestamp":1755405422,"startTime":"0","endTime":"0","summary":"不少投资人感慨，一款GLP-1，就能炒到260亿港币。开盘暴涨280%，最终收于57.25港元，较发行价18.68港元涨幅高达206.48%，总市值飙升至260亿港元。银诺医药的核心吸引力在于其“国产GLP-1首秀”的光环，依苏帕格鲁肽α于2025年1月获批用于治疗2型糖尿病，是国内首个超长效GLP-1受体激动剂。据动脉网统计，截至8月8日，国内有212项围绕减重适应症的GLP-1，正处于一期至三期临床试验阶段。随着仿制药入局，GLP-1类药物价格体系面临重构。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250817123957974c8c34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250817123957974c8c34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLP","BK4144","BK4590"],"gpt_icon":0},{"id":"2560770922","title":"医药行业周报：全球GLP-1市场稳定扩容 关注国内企业的授权机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2560770922","media":"华鑫证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560770922?lang=zh_cn&edition=fundamental","pubTime":"2025-08-17 00:00","pubTimestamp":1755360000,"startTime":"0","endTime":"0","summary":"全球交易数量与金额均呈现显著上升态势。上半年全球GLP-1的销售额超过336亿美元，全年销售将超过600亿美元。全球GLP-1研发管线新变化也为中国企业提供了新的机遇，其中辉瑞宣布全面终止自有GLP-1 管线研发，但仍继续重视慢病方向，继续寻求合作机会。根据国家医保局解读，国家医保局共收到商保创新药目录申报信息141份，涉及药品通用名141个，经初步审核，121个药品通用名通过形式审查。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250817210631a48dbea9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250817210631a48dbea9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4590","BK4144","GLP"],"gpt_icon":0},{"id":"2559944182","title":"诺和诺德(NVO.US)GLP-1赛道再下一城：Wegovy获FDA批准用于治疗肝病，近1500万美国患者适用","url":"https://stock-news.laohu8.com/highlight/detail?id=2559944182","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559944182?lang=zh_cn&edition=fundamental","pubTime":"2025-08-16 08:52","pubTimestamp":1755305525,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，诺和诺德畅销减肥药Wegovy已获得美国食品药品监督管理局的批准，可用于治疗一种严重的肝脏疾病。这一批准使诺和诺德在这一蓬勃发展的 GLP-1 药物市场中获得了又一先发优势。截至发稿，诺和诺德盘后上涨了7.14%。在一项研究中，Wegovy使 37%的患者肝纤维化状况得到改善，且未加剧炎症反应，而接受安慰剂治疗的患者中仅有 22%的情况有所改善。他说，Wegovy不仅阻止了这些患者病情的恶化，还帮助修复了肝脏所受到的损伤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1330520.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK4599","IE00BKVL7J92.USD","BK4144","BK4532","BK4007","BK4585","LU1093756168.USD","IE00BZ1G4Q59.USD","GLP","LU1093756325.SGD","LU0154236417.USD","BK4590","NVO"],"gpt_icon":1},{"id":"2559494165","title":"司美格鲁肽获FDA批准治疗MASH","url":"https://stock-news.laohu8.com/highlight/detail?id=2559494165","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559494165?lang=zh_cn&edition=fundamental","pubTime":"2025-08-16 06:58","pubTimestamp":1755298710,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1583","603259","LU0456842615.SGD","LU2045819591.USD","LU1093756168.USD","LU2125910500.SGD","LU0708995583.HKD","GLP","LU2328871848.SGD","LU1093756325.SGD","LU1997245177.USD","LU1997244956.HKD","LU2488822045.USD","NVO","LU1969619763.USD","LU2495084118.USD","BK4588","BK1576","BK4007","LU1979443071.USD","BK0216","BK4144","IE00BKVL7J92.USD","LU1997245094.SGD","02359","IE00BZ1G4Q59.USD","BK4585","LU1934453819.USD","LU0154236417.USD","LU0052750758.USD","161030","LU2242644610.SGD","BK1141","LU0320764599.SGD","BK4590","LU1046422090.SGD","BK4532","BK4599"],"gpt_icon":0},{"id":"2559913262","title":"资本也爱GLP-1，认购比蜜雪冰城还火爆！银诺医药敲钟港股，盘中暴涨近300%","url":"https://stock-news.laohu8.com/highlight/detail?id=2559913262","media":"时代财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559913262?lang=zh_cn&edition=fundamental","pubTime":"2025-08-15 16:32","pubTimestamp":1755246775,"startTime":"0","endTime":"0","summary":"8月15日，本土GLP-1药企银诺医药-B正式在港股敲钟，发行价为18.68港元/股。2024年年底，银诺医药首次向港交所主板提交上市申请书。趁着GLP-1减肥药的“东风”，叠加港股创新药板块回暖，银诺医药新股认购异常火爆。截至目前，银诺医药已有一款GLP-1一类创新药上市。在今年618期间，怡诺轻在京东、阿里分别取得了内分泌用药第七名和GLP-1药物第三名的成绩。业绩方面，银诺医药在2023年和2024年年内分别亏损7.33亿元、1.75亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815163750a6e7de7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815163750a6e7de7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4144","YANG","GLP","02591","BK4590","BK4614"],"gpt_icon":1},{"id":"2559864995","title":"国产 GLP-1 先锋杀入港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2559864995","media":"Insight数据库","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559864995?lang=zh_cn&edition=fundamental","pubTime":"2025-08-15 07:40","pubTimestamp":1755214853,"startTime":"0","endTime":"0","summary":"8 月 15 日，银诺医药将正式在港交所主板挂牌上市，中信证券、中金公司担任联席保荐人。截至 2025 年 5 月 31 日，分销网络由 20 家分销商组成，横跨中国 13 个省份、直辖市及自治区。截至 2025 年 5 月 31 日，该药在中国的销售额达3810 万元，在竞争激烈的 GLP-1 赛道中撕开了一道国产替代的裂缝。与依苏帕格鲁肽α 和其他 GLP-1 药物不同，YN203 是一种靶向 GCGR 信号通路的重组融合蛋白，用于治疗 T2D。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815084348a4897d2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815084348a4897d2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4144","BK4590","GLP"],"gpt_icon":0},{"id":"2559963122","title":"银诺医药-B(02591)暗盘暴涨270%引市场聚焦GLP-1赛道，派格生物医药-B(02565)价值洼地增长可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2559963122","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559963122?lang=zh_cn&edition=fundamental","pubTime":"2025-08-14 23:19","pubTimestamp":1755184741,"startTime":"0","endTime":"0","summary":"GLP-1赛道方兴未艾，获市场高度关注智通财经APP观察到，近日专注于GLP-1类药物研发的银诺医药-BIPO上市，其暗盘暴涨超270%，市值超324亿港币，而这反映的正是资本市场对于GLP-1类药物赛道以及内分泌疾病治疗市场的关注。实际上，在当下港市GLP-1类药物赛道中并不乏优质标的，派格生物医药-B便是其中的稀缺价值标的。而GLP-1RA因其可带来多重获益，在国内外各大指南中地位逐步提升，目前已被列为T2DM患者的一线治疗药物，维培那肽便是其中之一。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1329859.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4590","02591","BK1161","02565","399441","BK4144","161726","GLP"],"gpt_icon":1},{"id":"2559985227","title":"创新药动态更新：GLP-1小分子：口服GLP-1小分子受体激动剂达到三期临床终点，国产潜在BIC管线在美国临床展示减重潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2559985227","media":"山西证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559985227?lang=zh_cn&edition=fundamental","pubTime":"2025-08-14 00:05","pubTimestamp":1755101158,"startTime":"0","endTime":"0","summary":"药物点评口服GLP-1小分子受体激动剂是2型糖尿病、肥胖/减重药物。礼来口服小分子GLP-1RAOrforglipron达到2型糖尿病、肥胖/超重III期临床终点即将申报上市。相比Orforglipron，歌礼制药潜在BIC的口服小分子GLP-1RAASC30有更优的半衰期、药物暴露量、活性，剂量滴定更快；临床展现初步减重疗效。Orforglipron和ASC30耐受性良好，与GLP-1类药物一致，胃肠道相关不良事件为轻中度，未观察到肝脏安全性信号。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508140006009745b4ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508140006009745b4ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4144","GLP","BK4590"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":2,"totalSize":149,"code":"91000000","status":"200"}]}}